Founder, Nurix and Lyterian Therapeutics
Excited about stress responses, ubiquitin, proteasome, targeted protein degradation, drug discovery
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
aprecruit.berkeley.edu/JPF05098
aprecruit.berkeley.edu/JPF05098
aprecruit.berkeley.edu/JPF05098
aprecruit.berkeley.edu/JPF05098
www.jccfund.org/wp-content/u...
www.jccfund.org/wp-content/u...
Brief Skytorial!
1/9
@mti-ucb.bsky.social member @olzmannlab.bsky.social for receiving the Beatriz Manz award for 'transformational teaching and community service'. Glad to have you as a friend and colleague @ucberkeleyofficial.bsky.social, James!
@mti-ucb.bsky.social member @olzmannlab.bsky.social for receiving the Beatriz Manz award for 'transformational teaching and community service'. Glad to have you as a friend and colleague @ucberkeleyofficial.bsky.social, James!
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
His lab is developing selective inhibitors of parasite-specific kinesins - a new and safer strategy to treat African sleeping sickness and related diseases.
A leap forward in neglected tropical disease drug discovery.
#MTI #GlobalHealth
www.nature.com/articles/s41...
www.nature.com/articles/s41...
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
His lab is using FRET-based biosensors to find compounds that fine-tune glutamate receptors - unlocking new treatments for depression, including hard-to-treat cases.
A new era of brain-targeted molecular therapeutics.
#MTI #Neurobiology #FRET
news.berkeley.edu/2025/04/22/t...
news.berkeley.edu/2025/04/22/t...
Proud to support 6 researchers with $90K + resources.
🔬Lareau: CRISPR for retinitis pigmentosa
🧪Hurley: Cancer inhibitors
✨Sherriff & Olzmann: Molecular glues
🥼Welch: Sleeping sickness
🧫Isacoff: Fast-acting antidepressants
Advancing innovation at Berkeley
@robzonculab.bsky.social @ucberkeleyofficial.bsky.social
www.embopress.org/doi/full/10....
sparkns.org/programs/pro...
sparkns.org/programs/pro...